EP Patent
EP3348262A1 — Methods for making dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
Assigned to Chrysalis Pharma AG · Expires 2018-07-18 · 8y expired
What this patent protects
Methods for making DPA-enriched pharmaceutical compositions of polyunsaturated fatty acids in free acid form are presented.
USPTO Abstract
Methods for making DPA-enriched pharmaceutical compositions of polyunsaturated fatty acids in free acid form are presented.
Drugs covered by this patent
- Epanova (OMEGA-3-CARBOXYLIC ACIDS) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.